|
![]() |
|||
|
Home / Market research shop / Kazakhstan pharma market KAZAKHSTAN PHARMA MARKET1. Kazakhstan Pharma Market: Nonsteroid Antirheumatic Drugs The report offers a general analysis of the group Antiinflammatory and Antirheumatic Products, non Steroids (M01A), as well as a comprehensive sales analysis of the groups Oxicams (M01AC) and Coxibs (M01AH) - the two preparation groups have much fewer side effects on GIT (erosive-ulcerous diseases) by selectively inhibiting COX-2 enzymes, what provides for their stronger effect on inflammatory tissue than on gastric and kidney mucosa. 2. Kazakhstan Retail Pharma Market: Urology Drugs The report analyzes the retail sales of urologicals (ATC group G04) 3. Kazakhstan Retail Pharma Market: Throat Preparations The report analyzes the market segment of throat preparations (EPhMRA group R2) 4. Kazakhstan Retail Pharma Market: Preparations for Treatment of Colds and Acute Respiratory Diseases The report analyzes the market segment of preparations for treatment of colds and acute respiratory diseases (selected on the basis of the pharmaceutical group classification). 5. Kazakhstan Retail Pharma Market: Topical Nasal Preparations The report examines the market segment of preparations for topical treatment of nasal diseases (group R1A by EPhMRA classification). 6. Kazakhstan Retail Pharma Market: Plain Ace Inhibitors The report examines the market segment of preparations belonging to ATC group C09A (angiotenzin-converting enzyme inhibitors - ACEI). 7. Kazakhstan Pharma Market: Macrolides The report examines the market segment of antibacterials for systemic use - group J01F (Macrolides, Lincosamides and Streptogramins) by ATC classification. 8. Kazakhstan Market of Glucocorticosteroids for Topical Treatment of Skin Diseases The report examines the Kazakhstan market of dermatological glucocorticosteroids of ATC group D07A (Corticosteroids, Dermatological Preparations). 9. Kazakhstan Retail Pharma Market: Antihistamine Drugs The report examines retail sales of R06 group by ATC classification - Antihistamines for Systemic Use - in 2005. |
|||||||||||||||||||||||
"RMBC" Analytical studies of the Pharmaceutical Industry. 1996-2008. All rights reserved. |
||||||||||||||||||||||||